SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Opko Health, Inc. – ‘10-K’ for 12/31/14 – ‘EX-32.2’

On:  Friday, 2/27/15, at 4:47pm ET   ·   For:  12/31/14   ·   Accession #:  944809-15-3   ·   File #:  1-33528

Previous ‘10-K’:  ‘10-K’ on 3/3/14 for 12/31/13   ·   Next:  ‘10-K/A’ on 4/30/15 for 12/31/14   ·   Latest:  ‘10-K’ on 3/1/24 for 12/31/23   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/27/15  Opko Health, Inc.                 10-K       12/31/14  109:23M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.36M 
 2: EX-10.23    Material Contract                                   HTML    483K 
 3: EX-21       Subsidiaries List                                   HTML     31K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     32K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     35K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     35K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     29K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     29K 
74: R1          Document and Entity Information                     HTML     57K 
59: R2          Consolidated Balance Sheets (Unaudited)             HTML    141K 
71: R3          Consolidated Balance Sheets (Unaudited)             HTML     39K 
                (Parenthetical)                                                  
78: R4          Consolidated Statements of Operations (Unaudited)   HTML    128K 
99: R5          Consolidated Statements of Comprehensive Loss       HTML     67K 
                (Unaudited)                                                      
62: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML    251K 
70: R7          Condensed Consolidated Statements of Cash Flows     HTML     31K 
                (Unaudited) (Parenthetical)                                      
53: R8          Condensed Consolidated Statement of Equity          HTML    222K 
43: R9          Condensed Consolidated Statement of Shareholders'   HTML     42K 
                Equity (Unaudited) (Parenthetical)                               
101: R10         Business and Organization                           HTML     37K  
80: R11         Summary of Significant Accounting Policies          HTML     77K 
79: R12         Loss Per Share                                      HTML     36K 
86: R13         Acquisitions, Investments, and Licenses             HTML    140K 
87: R14         Composition of Certain Financial Statement          HTML    294K 
                Captions                                                         
84: R15         Debt                                                HTML    160K 
88: R16         Shareholders' Equity                                HTML     57K 
72: R17         Accumulated Other Comprehensive Income              HTML     67K 
75: R18         Equity-Based Compensation                           HTML     82K 
82: R19         Income Taxes                                        HTML    150K 
109: R20         Related Party Transactions                          HTML     58K  
95: R21         Employee Benefit Plans                              HTML     31K 
66: R22         Commitments and Contingencies                       HTML     41K 
81: R23         Strategic Alliances                                 HTML     38K 
68: R24         Leases                                              HTML     40K 
34: R25         Segments                                            HTML    138K 
96: R26         Fair Value Measurements                             HTML    225K 
105: R27         Derivative Contracts                                HTML    104K  
48: R28         Selected Quarterly Financial Data (Unaudited)       HTML     68K 
47: R29         Subsequent Events                                   HTML     30K 
51: R30         Summary of Significant Accounting Policies          HTML    146K 
                (Policies)                                                       
52: R31         Acquisitions, Investments, and Licenses (Tables)    HTML    112K 
54: R32         Composition of Certain Financial Statement          HTML    300K 
                Captions (Tables)                                                
23: R33         Debt (Tables)                                       HTML    156K 
93: R34         Shareholders' Equity (Tables)                       HTML     44K 
64: R35         Accumulated Other Comprehensive Income (Tables)     HTML     62K 
67: R36         Equity-Based Compensation (Tables)                  HTML     67K 
38: R37         Income Taxes (Tables)                               HTML    148K 
108: R38         Leases (Tables)                                     HTML     36K  
15: R39         Segments (Tables)                                   HTML    131K 
56: R40         Fair Value Measurements (Tables)                    HTML    223K 
98: R41         Derivative Contracts (Tables)                       HTML    104K 
36: R42         Selected Quarterly Financial Data (Unaudited)       HTML     67K 
                (Tables)                                                         
46: R43         Summary of Significant Accounting Policies          HTML    187K 
                (Details)                                                        
50: R44         Loss Per Share (Details)                            HTML     44K 
60: R45         Acquisitions, Investments, and Licenses - Textual   HTML    233K 
                (Details)                                                        
22: R46         Acquisitions, Investments, and Licenses - Summary   HTML     94K 
                of Assets Acquired and Liabilities Assumed                       
                (Details)                                                        
42: R47         Acquisitions, Investments, and Licenses - Summary   HTML     42K 
                of Pro Forma Results (Details)                                   
17: R48         Acquisitions, Investments, and Licenses - Summary   HTML     45K 
                of Investments (Details)                                         
97: R49         Acquisitions, Investments, and Licenses - Schedule  HTML    112K 
                of Consolidated Assets and Non-Recourse                          
                Liabilities (Details)                                            
35: R50         Composition of Certain Financial Statement          HTML    203K 
                Captions (Details)                                               
94: R51         Composition of Certain Financial Statement          HTML    167K 
                Captions (Details 1)                                             
39: R52         Composition of Certain Financial Statement          HTML     61K 
                Captions (Details 2)                                             
57: R53         Composition of Certain Financial Statement          HTML    120K 
                Captions (Details 3)                                             
16: R54         Debt - Notes (Details)                              HTML     90K 
20: R55         Debt - Inputs Used In Lattice Model (Details)       HTML     63K 
49: R56         Debt - Fair Value Of Embedded Derivatives           HTML     39K 
                (Details)                                                        
27: R57         Debt - Lines Of Credit (Details)                    HTML     86K 
102: R58         Debt - Mortgage Notes And Other Debt (Details)      HTML     43K  
63: R59         Debt - Textual (Details)                            HTML    130K 
85: R60         Shareholders' Equity (Details)                      HTML     52K 
41: R61         Shareholders' Equity (Details Textual)              HTML     92K 
44: R62         Accumulated Other Comprehensive Income (Details)    HTML     61K 
92: R63         Accumulated Other Comprehensive Income (Details     HTML     40K 
                Textual)                                                         
89: R64         Equity-Based Compensation (Details Textual)         HTML     90K 
65: R65         Equity-Based Compensation (Details)                 HTML     55K 
91: R66         Equity-Based Compensation (Details 1)               HTML     89K 
40: R67         Income Taxes (Details)                              HTML     69K 
69: R68         Income Taxes (Details 1)                            HTML     84K 
104: R69         Income Taxes (Details 2)                            HTML     44K  
19: R70         Income Taxes (Details 3)                            HTML     60K 
33: R71         Income Taxes (Details 4)                            HTML     38K 
58: R72         Income Taxes (Details 5)                            HTML     35K 
25: R73         Income Taxes (Details Textual)                      HTML     81K 
107: R74         Related Party Transactions - Textual (Details)      HTML    470K  
37: R75         Employee Benefit Plans (Details)                    HTML     37K 
28: R76         Commitments and Contingencies (Details)             HTML     53K 
32: R77         Strategic Alliances Strategic Alliances (Details)   HTML     71K 
21: R78         Leases (Details Textual)                            HTML     30K 
24: R79         Leases (Details)                                    HTML     48K 
76: R80         Segments (Details Textual)                          HTML     61K 
30: R81         Segments (Details)                                  HTML    154K 
103: R82         Fair Value Measurements - Summary Of Investments    HTML     57K  
                (Details)                                                        
55: R83         Fair Value Measurements - Assets And Liabilities    HTML     98K 
                Measured At Fair Value (Details)                                 
83: R84         Fair Value Measurements - Notes (Details)           HTML     33K 
90: R85         Fair Value Measurements - Level 3 Reconciliation    HTML     75K 
                (Details)                                                        
29: R86         Fair Value Measurements - Textual (Details)         HTML     54K 
31: R87         Derivative Contracts (Details)                      HTML     47K 
100: R88         Derivative Contracts (Details 1)                    HTML     40K  
26: R89         Derivative Contracts (Details 2)                    HTML     86K 
77: R90         Selected Quarterly Financial Data (Unaudited)       HTML     55K 
                (Details)                                                        
73: R91         Subsequent Events Subsequent Events (Details)       HTML     30K 
106: XML         IDEA XML File -- Filing Summary                      XML    172K  
18: EXCEL       IDEA Workbook of Financial Reports                  XLSX    407K 
45: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   3.59M 
 9: EX-101.INS  XBRL Instance -- opk-20141231                        XML   5.27M 
11: EX-101.CAL  XBRL Calculations -- opk-20141231_cal                XML    320K 
12: EX-101.DEF  XBRL Definitions -- opk-20141231_def                 XML   1.47M 
13: EX-101.LAB  XBRL Labels -- opk-20141231_lab                      XML   3.20M 
14: EX-101.PRE  XBRL Presentations -- opk-20141231_pre               XML   1.92M 
10: EX-101.SCH  XBRL Schema -- opk-20141231                          XSD    297K 
61: ZIP         XBRL Zipped Folder -- 0000944809-15-000003-xbrl      Zip    468K 


‘EX-32.2’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  OPK - 12.31.2014 - EX 32.2  


Exhibit 32.2
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant section 906 of the Sarbanes-Oxley Act of 2002, I, Adam Logal, Chief Financial Officer of OPKO Health, Inc. (the “Company”), hereby certify that:
The Annual Report on Form 10-K for the year ended December 31, 2014 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
 
Senior Vice President, Chief Financial Officer
Chief Accounting Officer and Treasurer





Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/27/15
For Period end:12/31/1410-K/A,  4,  5,  ARS,  SD
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/18/21  Opko Health, Inc.                 10-K       12/31/20  111:16M
 7/13/15  SEC                               UPLOAD9/18/17    1:12K  Opko Health, Inc.
 6/29/15  SEC                               UPLOAD9/18/17    1:267K Opko Health, Inc.
Top
Filing Submission 0000944809-15-000003   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 12, 10:08:14.1am ET